Thomas Rüdiger

12.4k total citations
93 papers, 5.0k citations indexed

About

Thomas Rüdiger is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Thomas Rüdiger has authored 93 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Pathology and Forensic Medicine, 39 papers in Oncology and 24 papers in Immunology. Recurrent topics in Thomas Rüdiger's work include Lymphoma Diagnosis and Treatment (50 papers), Chronic Lymphocytic Leukemia Research (19 papers) and Cutaneous lymphoproliferative disorders research (18 papers). Thomas Rüdiger is often cited by papers focused on Lymphoma Diagnosis and Treatment (50 papers), Chronic Lymphocytic Leukemia Research (19 papers) and Cutaneous lymphoproliferative disorders research (18 papers). Thomas Rüdiger collaborates with scholars based in Germany, United States and Italy. Thomas Rüdiger's co-authors include Hans Konrad Müller‐Hermelink, German Ott, Dennis D. Weisenburger, Eva Geissinger, Andreas Zettl, Peter Reimer, Jamés O. Armitage, Bharat N. Nathwani, H. K. Müller-Hermelink and Andreas Rosenwald and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Thomas Rüdiger

90 papers receiving 4.9k citations

Peers

Countries citing papers authored by Thomas Rüdiger

Since Specialization

Citations

This map shows the geographic impact of Thomas Rüdiger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Rüdiger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Rüdiger more than expected).

Fields of papers citing papers by Thomas Rüdiger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Rüdiger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Rüdiger. The network helps show where Thomas Rüdiger may publish in the future.

Co-authorship network of co-authors of Thomas Rüdiger

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Rüdiger. A scholar is included among the top collaborators of Thomas Rüdiger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Rüdiger. Thomas Rüdiger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Advancements in Interoperability: Achieving Anatomic Pathology Reports That Adhere to International Standards and Are Both Human-Readable and Readily Computable 2025 ·JCO Clinical Cancer Informatics ·W. Scott Campbell, Brian Rous, Stefan V. Dubois, (unknown), Rajesh Dash, Thomas Rüdiger, (unknown), (unknown), James T. Case, Laszlo Igali, Mary E. Edgerton, (unknown), (unknown), George Birdsong, (unknown), Timothy R. Helliwell, Peter Paul Yu, John R. Srigley	2
2	Consumer behaviour survey for assessing exposure from consumer products: a feasibility study 2018 ·Journal of Exposure Science & Environmental Epidemiology ·Klaus Schneider, (unknown), (unknown), (unknown), Henrike Berkefeld, (unknown), Thomas Rüdiger, Oliver Lindtner, Jan Oltmanns	3
3	Multi-center evaluation of the novel fully-automated PCR-based Idylla™ BRAF Mutation Test on formalin-fixed paraffin-embedded tissue of malignant melanoma 2015 ·Experimental and Molecular Pathology ·Linea Cecilie Melchior, Morten Grauslund, Beatríz Bellosillo, Clara Montagut, (unknown), (unknown), (unknown), Johan Frans, (unknown), Claire Bourgain, (unknown), Robert van der Geize, Kristof Cokelaere, (unknown), (unknown), Thomas Rüdiger, (unknown), Martin Reijans, (unknown)	37
4	Standardized Ki67 Diagnostics Using Automated Scoring—Clinical Validation in the GeparTrio Breast Cancer Study 2014 ·Clinical Cancer Research ·Frederick Klauschen, Stephan Wienert, Wolfgang Schmitt, Sibylle Loibl, Bernd Gerber, Jens‐Uwe Blohmer, Jens Huober, Thomas Rüdiger, E Erbstösser, Keyur Mehta, Bianca Lederer, Manfred Dietel, Carsten Denkert, Gϋnter von Minckwitz	78
5	Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes 2014 ·BMC Cancer ·Silvia Darb‐Esfahani, Gϋnter von Minckwitz, Carsten Denkert, Beyhan Ataseven, B. Högel, Keyur Mehta, (unknown), Thomas Rüdiger, Berit M. Pfitzner, K. Kittel, (unknown), Klaus Baumann, Roland Moll, Manfred Dietel, Holger Eidtmann, Christoph Thomssen, Sibylle Loibl	67
6	Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial 2013 ·Annals of Oncology ·Carsten Denkert, Sibylle Loibl, Berit Müller, Holger Eidtmann, Wolfgang Schmitt, W. Eiermann, B. Gerber, Hans Tesch, J. Hilfrich, Jens Huober, Tanja Fehm, Jana Barinoff, Christian Jackisch, Judith Prinzler, Thomas Rüdiger, E Erbstösser, Jens‐Uwe Blohmer, Jan Budczies, K. Mehta, Gϋnter von Minckwitz	172
7	Birt-Hogg-Dubé-Syndrom 2010 ·Der Urologe ·(unknown), Thomas Rüdiger, (unknown), D. Frohneberg	0
8	Expression of microRNA‐221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence 2009 ·International Journal of Cancer ·Martin Spahn, Susanne Kneitz, Claus Jürgen Scholz, (unknown), Thomas Rüdiger, Philipp Ströbel, H. Riedmiller, Burkhard Kneitz	189
9	Analysis of single nucleotide polymorphisms in the FAS and CTLA-4 genes of peripheral T-cell lymphomas 2008 ·Journal of Hematopathology ·Irina Bonzheim, Eva Geissinger, Wen‐Yu Chuang, Sabine Roth, Philipp Ströbel, Alexander Marx, Peter Reimer, Martin Wilhelm, Bernhard Puppe, Andreas Rosenwald, Hans Konrad Müller‐Hermelink, Thomas Rüdiger	11
10	‘Normal counterparts’ of nodal peripheral T‐cell lymphoma 2006 ·Hematological Oncology ·Thomas Rüdiger, Eva Geissinger, Hans Konrad Müller‐Hermelink	26
11	Nodal peripheral T‐cell lymphomas correspond to distinct mature T‐cell populations 2006 ·The Journal of Pathology ·Eva Geissinger, Irina Bonzheim, László Krenács, Sabine Roth, Peter Reimer, Martin Wilhelm, (unknown), Thomas Rüdiger	13
12	Periphere NK/T-Zell-Lymphome 2006 ·Der Pathologe ·Thomas Rüdiger, Andreas Zettl, Patrick Adam, Irina Bonzheim, Eva Geissinger, H K Müller‐Hermelink	1
13	Composite marginal zone B‐cell lymphoma and classical Hodgkin's lymphoma: a clinicopathological study of 12 cases 2005 ·Histopathology ·Andreas Zettl, Thomas Rüdiger, Anna‐Friederike Marx, H K Müller‐Hermelink, German Ott	36
14	Medical history and risk for lymphoma: results of a population-based case-control study in Germany 2004 ·European Journal of Cancer ·Nikolaus Becker, Evelin Deeg, Thomas Rüdiger, Alexandra Nieters	40
15	Female Patient with a History of Hashimoto’s Thyroiditis, Diagnosed with MALT Lymphoma of Both Breasts 2003 ·Oncology Research and Treatment ·Doris Kraemer, Florian Weißinger, Peter Reimer, Volker Kunzmann, Thomas Rüdiger, Mathias Wilhelm	3
16	Angioimmunoblastic T cell lymphoma is derived from mature T‐helper cells with varying expression and loss of detectable CD4 2002 ·International Journal of Cancer ·Seung‐Sook Lee, Thomas Rüdiger, (unknown), Sabine Roth, Petr Starostik, Hans Konrad Müller‐Hermelink	52
17	Tissue Array Technology for Testing Interlaboratory and Interobserver Reproducibility of Immunohistochemical Estrogen Receptor Analysis in a Large Multicenter Trial 2002 ·American Journal of Clinical Pathology ·Reinhard von Wasielewski, Michael Mengel, Birgitt Wiese, Thomas Rüdiger, Hans Konrad Müller‐Hermelink, Hans Kreipe	88
18	Epstein-Barr Virus–Associated B-Cell Lymphoproliferative Disorders in Angioimmunoblastic T-Cell Lymphoma and Peripheral T-Cell Lymphoma, Unspecified 2002 ·American Journal of Clinical Pathology ·Andreas Zettl, (unknown), Thomas Rüdiger, Petr Starostik, Mirella Marino, Thomas Kirchner, Michaela Ott, Hans Konrad Müller‐Hermelink, German Ott	159
19	Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell/histiocyte‐rich B cell lymphoma 2002 ·Annals of Oncology ·Thomas Rüdiger, R. D. Gascoyne, (unknown), Daphne de Jong, Jan Delabie, Chris De Wolf‐Peeters, S Poppema, Luc Xerri, C Gisselbrecht, S. Wiedenmann, H. K. Müller-Hermelink	69
20	Differential Diagnosis Between Classic Hodgkin's Lymphoma, T-Cell-Rich B-Cell Lymphoma, and Paragranuloma by Paraffin Immunohistochemistry 1998 ·The American Journal of Surgical Pathology ·Thomas Rüdiger, German Ott, M. Michaela Ott, Sigrid Müller‐Deubert, Hans Konrad Müller‐Hermelink	84

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact